Lakshmikumaran and Sridharan logo

Articles

C

Minor variations, major consequences: Bombay High Court on pharmaceutical trademark infringement and trade-dress copying

The article discusses the Bombay High Court’s decision in Blue Cross Laboratories Pvt. Ltd. v. Alto Healthcare Pvt. Ltd., where the Court held that the mark ‘MEFIAL-SPAS’ infringed Blue Cross’s registered pharmaceutical mark ‘MEFTAL-SPAS’. It emphasized that even minor spelling changes can cause deceptive similarity in pharmaceutical products, where confusion may affect public health. The Court also found infringement of copyright and trade dress due to imitation of packaging, colour scheme, and artwork. According to the authors, commercial courts are becoming increasingly ready to make a considerable effort to punish those infringers who act deliberately, fraudulently, and opportunistically.

Khushi Lokwani+131 Aug 2026
C2

Cancellation risk for GPU-based NPOs diluted: A shift under the Income-tax Act, 2025

The article examines how the amendment by the Finance Act, 2026 in the Income-tax Act, 2025 changes the consequences for not-for-profit organisations (‘NPOs’) pursuing general public utility objects. The 2026 amendment removes many breaches from the ‘specified violations’, thus reducing the risk of cancellation. The authors however note that non-compliance may still lead to denial of exemption, taxation of commercial income, and scrutiny of charitable purpose. According to them, the change offers operational flexibility while preserving discipline governing NPOs.

Ravi Sawana+124 Aug 2026

Search Articles